This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dybdahl, M. Articles by Nexø, B. A. Search for Related Content PubMed PubMed Citation Articles by Dybdahl, M. Articles by Nexø, B. A.

Polymorphisms in the DNA Repair Gene XPD: Correlations with Risk and Age at Onset of Basal Cell Carcinoma¹

National Institute of Occupational Health, DK-2100 Copenhagen, Denmark [M. D., U. V., H. W., B. A. N.], and Institute of Preventive Medicine, Kommunehospitalet, DK-1399 Copenhagen, Denmark [G. F.]

The XPD protein has a dual function, both in nucleotide excision repair and in basal transcription. We have studied the role of two nucleotide substitutions in the XPD gene, one in exon 23 leading to an amino acid substitution (Lys751Gln) and one silent in exon 6 in relation to basal cell carcinoma (BCC). Both are two-allele polymorphisms, with the nucleobases A and C at the given positions. We genotyped psoriasis patients with and without BCC and nonpsoriatic persons with and without BCC (4 x 20 persons). The choice to study psoriasis patients was motivated by their high genotoxic exposure via treatment and their high relative rate of early BCC. Subjects carrying two A alleles (AA genotype) in exon 23 were at 4.3-fold higher risk of BCC than subjects with two C alleles (95% CI, 0.79–23.57). In addition, the mean age at first skin tumor for BCC cases with the AA genotype was significantly lower than the mean age for BCC cases with the AC or CC genotype (P = 0.012). Thus, the variant C-allele of exon 23 may be protective. The exon 6 genotype was associated with the risk of BCC among the psoriasis patients; psoriatics carrying two A alleles in exon 6 were at 5.3-fold higher risk of BCC than psoriatics with two C alleles (95% CI, 0.78–36.31). For the psoriatics, the mean age at onset of BCC for cases with the AA genotype was marginally lower than the mean age for cases with genotype AC or CC (P = 0.060). Our results raise the possibility that the polymorphisms in the XPD gene may be contributing factors in the risk of BCC development. They are, therefore, important candidates for future studies in susceptibility to cancer.

This article has been cited by other articles:

				K. M. McCarty, T. J. Smith, W. Zhou, E. Gonzalez, Q. Quamruzzaman, M. Rahman, G. Mahiuddin, L. Ryan, L. Su, and D. C. Christiani Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions Carcinogenesis, August 1, 2007; 28(8): 1697 - 1702. [Abstract] [Full Text] [PDF]

				M. Banerjee, J. Sarkar, J. K. Das, A. Mukherjee, A. K. Sarkar, L. Mondal, and A. K. Giri Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and significant chromosome aberrations Carcinogenesis, March 1, 2007; 28(3): 672 - 676. [Abstract] [Full Text] [PDF]

				S. Queille, L. Luron, A. Spatz, M. F. Avril, V. Ribrag, P. Duvillard, C. Hiesse, A. Sarasin, J. P. Armand, and L. Daya-Grosjean Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene Carcinogenesis, March 1, 2007; 28(3): 724 - 731. [Abstract] [Full Text] [PDF]

				W. Ye, R. Kumar, G. Bacova, J. Lagergren, K. Hemminki, and O. Nyren The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden Carcinogenesis, September 1, 2006; 27(9): 1835 - 1841. [Abstract] [Full Text] [PDF]

				M. Manuguerra, F. Saletta, M. R. Karagas, M. Berwick, F. Veglia, P. Vineis, and G. Matullo XRCC3 and XPD/ERCC2 Single Nucleotide Polymorphisms and the Risk of Cancer: A HuGE Review Am. J. Epidemiol., August 15, 2006; 164(4): 297 - 302. [Abstract] [Full Text] [PDF]

				L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385. [Abstract] [Full Text] [PDF]

				R. C. Millikan, A. Hummer, C. Begg, J. Player, A. R. de Cotret, S. Winkel, H. Mohrenweiser, N. Thomas, B. Armstrong, A. Kricker, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study Carcinogenesis, March 1, 2006; 27(3): 610 - 618. [Abstract] [Full Text] [PDF]

				A. G. Casson, Z. Zheng, S. C. Evans, P. J. Veugelers, G. A. Porter, and D. L. Guernsey Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma Carcinogenesis, September 1, 2005; 26(9): 1536 - 1541. [Abstract] [Full Text] [PDF]

				C. J. Marsit, J. K. Wiencke, M. Liu, and K. T. Kelsey The race associated allele of Semaphorin 3B (SEMA3B) T415I and its role in lung cancer in African-Americans and Latino-Americans Carcinogenesis, August 1, 2005; 26(8): 1446 - 1449. [Abstract] [Full Text] [PDF]

				W.-Y. Huang, W.-H. Chow, N. Rothman, J. Lissowska, V. Llaca, M. Yeager, W. Zatonski, and R. B. Hayes Selected DNA repair polymorphisms and gastric cancer in Poland Carcinogenesis, August 1, 2005; 26(8): 1354 - 1359. [Abstract] [Full Text] [PDF]

				S. Blankenburg, I. R. Konig, R. Moessner, P. Laspe, K.-M. Thoms, U. Krueger, S. G. Khan, G. Westphal, C. Berking, M. Volkenandt, et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study Carcinogenesis, June 1, 2005; 26(6): 1085 - 1090. [Abstract] [Full Text] [PDF]

				M. B. Terry, M. D. Gammon, F. F. Zhang, S. M. Eng, S. K. Sagiv, A. B. Paykin, Q. Wang, S. Hayes, S. L. Teitelbaum, A. I. Neugut, et al. Polymorphism in the DNA Repair Gene XPD, Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2053 - 2058. [Abstract] [Full Text] [PDF]

				L. Hagmar, U. Stromberg, S. Bonassi, I.-L. Hansteen, L. E. Knudsen, C. Lindholm, and H. Norppa Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk: Results from Nordic and Italian Cohorts Cancer Res., March 15, 2004; 64(6): 2258 - 2263. [Abstract] [Full Text] [PDF]

				W.-M. Gao, M. Romkes, R. D. Day, J. M. Siegfried, J. D. Luketich, H. H. Mady, M. F. Melhem, and P. Keohavong Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer Carcinogenesis, October 1, 2003; 24(10): 1671 - 1676. [Abstract] [Full Text] [PDF]

				B. A. Nexo, U. Vogel, A. Olsen, T. Ketelsen, Z. Bukowy, B. L. Thomsen, H. Wallin, K. Overvad, and A. Tjonneland A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55 Carcinogenesis, May 1, 2003; 24(5): 899 - 904. [Abstract] [Full Text] [PDF]

				B. Faraglia, S. Y. Chen, M. D. Gammon, Y. Zhang, S. L. Teitelbaum, A. I. Neugut, H. Ahsan, G. C. Garbowski, H. Hibshoosh, D. Lin, et al. Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke Carcinogenesis, April 1, 2003; 24(4): 719 - 725. [Abstract] [Full Text] [PDF]

				X. Wu, H. Zhao, Q. Wei, C. I. Amos, K. Zhang, Z. Guo, Y. Qiao, W. K. Hong, and M. R. Spitz XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity Carcinogenesis, March 1, 2003; 24(3): 505 - 509. [Abstract] [Full Text] [PDF]

				E. L. Goode, C. M. Ulrich, and J. D. Potter Polymorphisms in DNA Repair Genes and Associations with Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1513 - 1530. [Abstract] [Full Text] [PDF]

				J. Yin, E. Rockenbauer, M. Hedayati, N. R. Jacobsen, U. Vogel, L. Grossman, L. Bolund, and B. A. Nexo Multiple Single Nucleotide Polymorphisms on Human Chromosome 19q13.2-3 Associate with Risk of Basal Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1449 - 1453. [Abstract] [Full Text] [PDF]

				S. Benhamou and A. Sarasin ERCC2/XPD gene polymorphisms and cancer risk Mutagenesis, November 1, 2002; 17(6): 463 - 469. [Abstract] [Full Text] [PDF]

				M. C. Stern, L. R. Johnson, D. A. Bell, and J. A. Taylor XPD Codon 751 Polymorphism, Metabolism Genes, Smoking, and Bladder Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1004 - 1011. [Abstract] [Full Text] [PDF]

				U. Vogel, P. Moller, L. Dragsted, S. Loft, A. Pedersen, and B. Sandstrom Inter-individual variation, seasonal variation and close correlation of OGG1 and ERCC1 mRNA levels in full blood from healthy volunteers Carcinogenesis, September 1, 2002; 23(9): 1505 - 1509. [Abstract] [Full Text] [PDF]

				S. Chen, D. Tang, K. Xue, L. Xu, G. Ma, Y. Hsu, and S. S. Cho DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population Carcinogenesis, August 1, 2002; 23(8): 1321 - 1325. [Abstract] [Full Text] [PDF]

				E. Rockenbauer, M. H. Bendixen, Z. Bukowy, J. Yin, N. R. Jacobsen, M. Hedayati, U. Vogel, L. Grossman, L. Bolund, and B. A. Nexo Association of chromosome 19q13.2-3 haplotypes with basal cell carcinoma: tentative delineation of an involved region using data for single nucleotide polymorphisms in two cohorts Carcinogenesis, July 1, 2002; 23(7): 1149 - 1153. [Abstract] [Full Text] [PDF]

				S.-M. Hou, S. Falt, S. Angelini, K. Yang, F. Nyberg, B. Lambert, and K. Hemminki The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk Carcinogenesis, April 1, 2002; 23(4): 599 - 603. [Abstract] [Full Text] [PDF]

				W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Gene-Environment Interaction for the ERCC2 Polymorphisms and Cumulative Cigarette Smoking Exposure in Lung Cancer Cancer Res., March 1, 2002; 62(5): 1377 - 1381. [Abstract] [Full Text] [PDF]

				Y. Qiao, M. R. Spitz, H. Shen, Z. Guo, S. Shete, M. Hedayati, L. Grossman, H. Mohrenweiser, and Q. Wei Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes Carcinogenesis, February 1, 2002; 23(2): 295 - 299. [Abstract] [Full Text] [PDF]

				D. J. Park, J. Stoehlmacher, W. Zhang, D. D. Tsao-Wei, S. Groshen, and H.-J. Lenz A Xeroderma Pigmentosum Group D Gene Polymorphism Predicts Clinical Outcome to Platinum-based Chemotherapy in Patients with Advanced Colorectal Cancer Cancer Res., December 1, 2001; 61(24): 8654 - 8658. [Abstract] [Full Text] [PDF]

				B. C. Broughton, M. Berneburg, H. Fawcett, E. M. Taylor, C. F. Arlett, T. Nardo, M. Stefanini, E. Menefee, V. H. Price, S. Queille, et al. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene Hum. Mol. Genet., October 1, 2001; 10(22): 2539 - 2547. [Abstract] [Full Text] [PDF]

				H. Seker, D. Butkiewicz, E. D. Bowman, M. Rusin, M. Hedayati, L. Grossman, and C. C. Harris Functional Significance of XPD Polymorphic Variants: Attenuated Apoptosis in Human Lymphoblastoid Cells with the XPD 312 Asp/Asp Genotype Cancer Res., October 1, 2001; 61(20): 7430 - 7434. [Abstract] [Full Text] [PDF]

				G. Matullo, D. Palli, M. Peluso, S. Guarrera, S. Carturan, E. Celentano, V. Krogh, A. Munnia, R. Tumino, S. Polidoro, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects Carcinogenesis, September 1, 2001; 22(9): 1437 - 1445. [Abstract] [Full Text] [PDF]

				K. Hemminki, G. Xu, S. Angelini, E. Snellman, C. T. Jansen, B. Lambert, and S.-M. Hou XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ Carcinogenesis, August 1, 2001; 22(8): 1185 - 1188. [Abstract] [Full Text] [PDF]

				U. Vogel, M. Hedayati, M. Dybdahl, L. Grossman, and B. A. Nexo Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited Carcinogenesis, June 1, 2001; 22(6): 899 - 904. [Abstract] [Full Text] [PDF]

				M. Caggana, J. Kilgallen, J. M. Conroy, J. K. Wiencke, K. T. Kelsey, R. Miike, P. Chen, and M. R. Wrensch Associations Between ERCC2 Polymorphisms and Gliomas Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 355 - 360. [Abstract] [Full Text]

				S. Emmert, T. D. Schneider, S. G. Khan, and K. H. Kraemer The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms Nucleic Acids Res., April 1, 2001; 29(7): 1443 - 1452. [Abstract] [Full Text] [PDF]

				D. Butkiewicz, M. Rusin, L. Enewold, P. G. Shields, M. Chorazy, and C. C. Harris Genetic polymorphisms in DNA repair genes and risk of lung cancer Carcinogenesis, April 1, 2001; 22(4): 593 - 597. [Abstract] [Full Text] [PDF]

				D. Tomescu, G. Kavanagh, T. Ha, H. Campbell, and D. W. Melton Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma Carcinogenesis, March 1, 2001; 22(3): 403 - 408. [Abstract] [Full Text] [PDF]

				M. R. Spitz, X. Wu, Y. Wang, L.-E Wang, S. Shete, C. I. Amos, Z. Guo, L. Lei, H. Mohrenweiser, and Q. Wei Modulation of Nucleotide Excision Repair Capacity by XPD Polymorphisms in Lung Cancer Patients Cancer Res., February 1, 2001; 61(4): 1354 - 1357. [Abstract] [Full Text]

				A. R. Lehmann The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases Genes & Dev., January 1, 2001; 15(1): 15 - 23. [Full Text]

				E. M. Sturgis, R. Zheng, L. Li, E. J. Castillo, S. A. Eicher, M. Chen, S. S. Strom, M. R. Spitz, and Q. Wei XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis Carcinogenesis, December 1, 2000; 21(12): 2219 - 2223. [Abstract] [Full Text] [PDF]

				M. Z. Hadi, M. A. Coleman, K. Fidelis, H. W. Mohrenweiser, and D. M. Wilson III Functional characterization of Ape1 variants identified in the human population Nucleic Acids Res., October 15, 2000; 28(20): 3871 - 3879. [Abstract] [Full Text] [PDF]

				S. G. Khan, E.J. Metter, R. E. Tarone, V. A. Bohr, L. Grossman, M. Hedayati, S. J. Bale, S. Emmert, and K. H. Kraemer A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism Carcinogenesis, October 1, 2000; 21(10): 1821 - 1825. [Abstract] [Full Text] [PDF]

				F. P. Perera Molecular Epidemiology: On the Path to Prevention? J Natl Cancer Inst, April 19, 2000; 92(8): 602 - 612. [Abstract] [Full Text] [PDF]

				R. M. Lunn, K. J. Helzlsouer, R. Parshad, D. M. Umbach, E. L. Harris, K. K. Sanford, and D. A. Bell XPD polymorphisms: effects on DNA repair proficiency Carcinogenesis, April 1, 2000; 21(4): 551 - 555. [Abstract] [Full Text] [PDF]

				F. P. Perera and I.B. Weinstein Molecular epidemiology: recent advances and future directions Carcinogenesis, March 1, 2000; 21(3): 517 - 524. [Abstract] [Full Text] [PDF]